WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing unit to New York-based Altaris LLC, easing worries that federal limits ...

Ranked among the top 1% of companies assessed in the pharmaceutical industry <li /> Recognized as a leader in Green CRDMO, driving innova ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

It is well known that WuXi entities have become dangerously entwined with American biotech. BGI Group's genomic data collection and ties to the Chinese military have alarmed national security ...

SHANGHAI, Jan. 12, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences ...

Chinese electric-car maker Li Auto and pharmaceutical company WuXi Apptec will join the Hang Seng Index as new constituents next month, according to the latest quarterly review by Hong Kong’s ...

STA Pharmaceutical Hong Kong Investment, the shareholder of WUXI XDC (02268.HK) 0.000 (0.000%) Short selling $1.70M; Ratio 2.675% , placed 37.8 million shares of the company at $3 ...